Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia
Identifieur interne : 002851 ( Pmc/Checkpoint ); précédent : 002850; suivant : 002852Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia
Auteurs : Siham Al Sinani ; Yusria Al Rawahi ; Hamed AbdoonSource :
- World Journal of Gastroenterology : WJG [ 1007-9327 ] ; 2012.
Abstract
A number of disorders have been described to cause protein losing enteropathy (PLE) in children. Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE. Few syndromes are associated with PIL; Hennekam syndrome (HS) is one of them. The principal treatment for PIL is a high protein, low fat diet with medium chain triglycerides supplementation. Supportive therapy includes albumin infusion. Few publications have supported the use of octreotide to diminish protein loss and minimize hypoalbuminemia seen in PIL. There are no publications on the treatment of PIL with octreotide in patients with HS. We report two children with HS and PLE in which we used octreotide to decrease intestinal protein loss. In one patient, octreotide increased serum albumin to an acceptable level without further need for albumin infusions. The other patient responded more dramatically with near normal serum albumin levels and cessation of albumin infusions. In achieving a good response to octreotide in both patients, we add to the publications supporting the use of octreotide in PIL and suggest that octreotide should be tried in patients with PIL secondary to HS. To the best of our knowledge, this is the first case report on the use of octreotide in HS-associated PIL.
Url:
DOI: 10.3748/wjg.v18.i43.6333
PubMed: 23180957
PubMed Central: 3501785
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:3501785Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia</title><author><name sortKey="Al Sinani, Siham" sort="Al Sinani, Siham" uniqKey="Al Sinani S" first="Siham" last="Al Sinani">Siham Al Sinani</name></author><author><name sortKey="Rawahi, Yusria Al" sort="Rawahi, Yusria Al" uniqKey="Rawahi Y" first="Yusria Al" last="Rawahi">Yusria Al Rawahi</name></author><author><name sortKey="Abdoon, Hamed" sort="Abdoon, Hamed" uniqKey="Abdoon H" first="Hamed" last="Abdoon">Hamed Abdoon</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23180957</idno><idno type="pmc">3501785</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501785</idno><idno type="RBID">PMC:3501785</idno><idno type="doi">10.3748/wjg.v18.i43.6333</idno><date when="2012">2012</date><idno type="wicri:Area/Pmc/Corpus">003221</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003221</idno><idno type="wicri:Area/Pmc/Curation">003220</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003220</idno><idno type="wicri:Area/Pmc/Checkpoint">002851</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002851</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia</title><author><name sortKey="Al Sinani, Siham" sort="Al Sinani, Siham" uniqKey="Al Sinani S" first="Siham" last="Al Sinani">Siham Al Sinani</name></author><author><name sortKey="Rawahi, Yusria Al" sort="Rawahi, Yusria Al" uniqKey="Rawahi Y" first="Yusria Al" last="Rawahi">Yusria Al Rawahi</name></author><author><name sortKey="Abdoon, Hamed" sort="Abdoon, Hamed" uniqKey="Abdoon H" first="Hamed" last="Abdoon">Hamed Abdoon</name></author></analytic><series><title level="j">World Journal of Gastroenterology : WJG</title><idno type="ISSN">1007-9327</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>A number of disorders have been described to cause protein losing enteropathy (PLE) in children. Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE. Few syndromes are associated with PIL; Hennekam syndrome (HS) is one of them. The principal treatment for PIL is a high protein, low fat diet with medium chain triglycerides supplementation. Supportive therapy includes albumin infusion. Few publications have supported the use of octreotide to diminish protein loss and minimize hypoalbuminemia seen in PIL. There are no publications on the treatment of PIL with octreotide in patients with HS. We report two children with HS and PLE in which we used octreotide to decrease intestinal protein loss. In one patient, octreotide increased serum albumin to an acceptable level without further need for albumin infusions. The other patient responded more dramatically with near normal serum albumin levels and cessation of albumin infusions. In achieving a good response to octreotide in both patients, we add to the publications supporting the use of octreotide in PIL and suggest that octreotide should be tried in patients with PIL secondary to HS. To the best of our knowledge, this is the first case report on the use of octreotide in HS-associated PIL.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">World J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">World J. Gastroenterol</journal-id><journal-id journal-id-type="publisher-id">WJG</journal-id><journal-title-group><journal-title>World Journal of Gastroenterology : WJG</journal-title></journal-title-group><issn pub-type="ppub">1007-9327</issn><publisher><publisher-name>Baishideng Publishing Group Co., Limited</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23180957</article-id><article-id pub-id-type="pmc">3501785</article-id><article-id pub-id-type="other">jWJG.v18.i43.pg6333</article-id><article-id pub-id-type="doi">10.3748/wjg.v18.i43.6333</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Al Sinani</surname><given-names>Siham</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rawahi</surname><given-names>Yusria Al</given-names></name></contrib><contrib contrib-type="author"><name><surname>Abdoon</surname><given-names>Hamed</given-names></name></contrib><aff>Siham Al Sinani, Yusria Al Rawahi, Hamed Abdoon, Child Health Department, Sultan Qaboos University Hospital, Muscat 123, Sultanate of Oman</aff></contrib-group><author-notes><fn><p>Author contributions: Al Sinani S participated in study concept, analysis of data, preparing the initial and final draft of the manuscript, critical revision of the manuscript for intellectual content and manuscript submission; Al Rawahi Y collected data and participated in the first draft of the case reports; Abdoon H cared for and started the first patient on octreotide.</p><p>Correspondence to: Siham Al Sinani, MD, FAAP, FRCPC, Child Health Department, Sultan Qaboos University Hospital, Al Khod, Muscat 123, Sultanate of Oman. <email>siham_ss@hotmail.com</email></p><p>Telephone: +968-241-43403 Fax: +968-241-43009</p></fn></author-notes><pub-date pub-type="ppub"><day>21</day><month>11</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>21</day><month>11</month><year>2012</year></pub-date><volume>18</volume><issue>43</issue><fpage>6333</fpage><lpage>6337</lpage><history><date date-type="received"><day>6</day><month>9</month><year>2011</year></date><date date-type="rev-recd"><day>23</day><month>4</month><year>2012</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2012</year></date></history><permissions><copyright-statement>©2012 Baishideng Publishing Group Co., Limited. All rights reserved.</copyright-statement><copyright-year>2012</copyright-year></permissions><abstract><p>A number of disorders have been described to cause protein losing enteropathy (PLE) in children. Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE. Few syndromes are associated with PIL; Hennekam syndrome (HS) is one of them. The principal treatment for PIL is a high protein, low fat diet with medium chain triglycerides supplementation. Supportive therapy includes albumin infusion. Few publications have supported the use of octreotide to diminish protein loss and minimize hypoalbuminemia seen in PIL. There are no publications on the treatment of PIL with octreotide in patients with HS. We report two children with HS and PLE in which we used octreotide to decrease intestinal protein loss. In one patient, octreotide increased serum albumin to an acceptable level without further need for albumin infusions. The other patient responded more dramatically with near normal serum albumin levels and cessation of albumin infusions. In achieving a good response to octreotide in both patients, we add to the publications supporting the use of octreotide in PIL and suggest that octreotide should be tried in patients with PIL secondary to HS. To the best of our knowledge, this is the first case report on the use of octreotide in HS-associated PIL.</p></abstract><kwd-group><kwd>Hennekam syndrome</kwd><kwd>Lymphangiectasia</kwd><kwd>Octreotide</kwd><kwd>Protein losing enteropathy</kwd></kwd-group></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Abdoon, Hamed" sort="Abdoon, Hamed" uniqKey="Abdoon H" first="Hamed" last="Abdoon">Hamed Abdoon</name><name sortKey="Al Sinani, Siham" sort="Al Sinani, Siham" uniqKey="Al Sinani S" first="Siham" last="Al Sinani">Siham Al Sinani</name><name sortKey="Rawahi, Yusria Al" sort="Rawahi, Yusria Al" uniqKey="Rawahi Y" first="Yusria Al" last="Rawahi">Yusria Al Rawahi</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002851 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 002851 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:3501785
|texte= Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:23180957" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |